Search research articles
Contact Us
Filters
Showing results (51-60 of 83) with videos related to
Page
of 9
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
January 9, 2023
Current diagnostic and clinical issues of screening for dihydropyrimidine dehydrogenase deficiency
Marie-Christine Etienne-Grimaldi, Nicolas Pallet, Valérie Boige, et al.
Clinical Pharmacokinetics
|
April 25, 2020
Population Pharmacokinetics of Ibrutinib and Its Dihydrodiol Metabolite in Patients with Lymphoid Malignancies
Fanny Gallais, Loïc Ysebaert, Fabien Despas, et al.
Journal for Immunotherapy of Cancer
|
September 24, 2024
Metabolic reprogramming of hypoxic tumor-associated macrophages through CSF-1R targeting favors treatment efficiency in colorectal cancers
Khaldoun Gharzeddine, Cristina Gonzalez Prieto, Marie Malier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 6, 2011
Thymidylate synthase genotype-directed neoadjuvant chemoradiation for patients with rectal adenocarcinoma
Benjamin R Tan, Fabienne Thomas, Robert J Myerson, et al.
Cancer Chemotherapy and Pharmacology
|
June 13, 2020
New DPYD variants causing DPD deficiency in patients treated with fluoropyrimidine
Xandra García-González, Bartosz Kaczmarczyk, Judith Abarca-Zabalía, et al.
Clinical Pharmacokinetics
|
March 9, 2026
Model-Informed Precision Dosing of Protein Kinase Inhibitors: Evaluation of Model-Averaging and Flattened Priors Methods
Félicien Le Louedec, Laura Morvan, Loïc Mourey, et al.
Cancer Management and Research
|
October 24, 2018
Severe toxicity to capecitabine due to a new variant at a donor splicing site in the dihydropyrimidine dehydrogenase <i>(DPYD)</i> gene
Xandra García-González, Sara López-Tarruella, María Isabel García, et al.
Pharmaceutical Research
|
July 18, 2020
Pharmacokinetic and Pharmacogenetic Study of Etoposide in High-Dose Protocol (TI-CE) for Advanced Germ Cell Tumors
Sotheara Moeung, Christine Chevreau, Sabrina Marsili, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
May 24, 2024
Identification of non-adherence to adjuvant letrozole using a population pharmacokinetics approach in hormone receptor-positive breast cancer patients
Alicja Puszkiel, Florence Dalenc, Naïma Tafzi, et al.
British Journal of Clinical Pharmacology
|
February 28, 2019
Cetuximab pharmacokinetic/pharmacodynamics relationships in advanced head and neck carcinoma patients
Félicien Le Louedec, Catherine Alix-Panabières, Thierry Lafont, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 83) with videos related to
Sort By:
Page
of 9
European Journal of Cancer (Oxford, England : 1990)
|
January 9, 2023
Current diagnostic and clinical issues of screening for dihydropyrimidine dehydrogenase deficiency
Marie-Christine Etienne-Grimaldi, Nicolas Pallet, Valérie Boige, et al.
Clinical Pharmacokinetics
|
April 25, 2020
Population Pharmacokinetics of Ibrutinib and Its Dihydrodiol Metabolite in Patients with Lymphoid Malignancies
Fanny Gallais, Loïc Ysebaert, Fabien Despas, et al.
Journal for Immunotherapy of Cancer
|
September 24, 2024
Metabolic reprogramming of hypoxic tumor-associated macrophages through CSF-1R targeting favors treatment efficiency in colorectal cancers
Khaldoun Gharzeddine, Cristina Gonzalez Prieto, Marie Malier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 6, 2011
Thymidylate synthase genotype-directed neoadjuvant chemoradiation for patients with rectal adenocarcinoma
Benjamin R Tan, Fabienne Thomas, Robert J Myerson, et al.
Cancer Chemotherapy and Pharmacology
|
June 13, 2020
New DPYD variants causing DPD deficiency in patients treated with fluoropyrimidine
Xandra García-González, Bartosz Kaczmarczyk, Judith Abarca-Zabalía, et al.
Clinical Pharmacokinetics
|
March 9, 2026
Model-Informed Precision Dosing of Protein Kinase Inhibitors: Evaluation of Model-Averaging and Flattened Priors Methods
Félicien Le Louedec, Laura Morvan, Loïc Mourey, et al.
Cancer Management and Research
|
October 24, 2018
Severe toxicity to capecitabine due to a new variant at a donor splicing site in the dihydropyrimidine dehydrogenase <i>(DPYD)</i> gene
Xandra García-González, Sara López-Tarruella, María Isabel García, et al.
Pharmaceutical Research
|
July 18, 2020
Pharmacokinetic and Pharmacogenetic Study of Etoposide in High-Dose Protocol (TI-CE) for Advanced Germ Cell Tumors
Sotheara Moeung, Christine Chevreau, Sabrina Marsili, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
May 24, 2024
Identification of non-adherence to adjuvant letrozole using a population pharmacokinetics approach in hormone receptor-positive breast cancer patients
Alicja Puszkiel, Florence Dalenc, Naïma Tafzi, et al.
British Journal of Clinical Pharmacology
|
February 28, 2019
Cetuximab pharmacokinetic/pharmacodynamics relationships in advanced head and neck carcinoma patients
Félicien Le Louedec, Catherine Alix-Panabières, Thierry Lafont, et al.
Page
of 9